P. Herzer

3.2k total citations · 1 hit paper
49 papers, 2.4k citations indexed

About

P. Herzer is a scholar working on Parasitology, Rheumatology and Infectious Diseases. According to data from OpenAlex, P. Herzer has authored 49 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Parasitology, 15 papers in Rheumatology and 13 papers in Infectious Diseases. Recurrent topics in P. Herzer's work include Vector-borne infectious diseases (16 papers), Viral Infections and Vectors (11 papers) and Bacteriophages and microbial interactions (6 papers). P. Herzer is often cited by papers focused on Vector-borne infectious diseases (16 papers), Viral Infections and Vectors (11 papers) and Bacteriophages and microbial interactions (6 papers). P. Herzer collaborates with scholars based in Germany, United States and Estonia. P. Herzer's co-authors include S Inouye, Masayori Inouye, Thomas S. Whittam, A. Zink, Joachim Listing, Matthias Schneider, Anja Strangfeld, S. Kary, Christian Antoni and Jörn Kekow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Bacteriology.

In The Last Decade

P. Herzer

47 papers receiving 2.3k citations

Hit Papers

Infections in patients with rheumatoid arthritis treated ... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Herzer Germany 21 932 482 478 460 390 49 2.4k
Kaisa Granfors Finland 42 2.4k 2.6× 651 1.4× 840 1.8× 1.5k 3.3× 882 2.3× 183 5.4k
Sohkichi Matsumoto Japan 31 327 0.4× 1.2k 2.5× 926 1.9× 805 1.8× 116 0.3× 165 3.3k
M M Frank United States 27 137 0.1× 159 0.3× 413 0.9× 1.5k 3.2× 588 1.5× 47 2.9k
Lourdes Isaac Brazil 25 148 0.2× 457 0.9× 215 0.4× 857 1.9× 275 0.7× 81 2.0k
Linda A. Lieberman United States 26 516 0.6× 224 0.5× 357 0.7× 1.4k 3.0× 63 0.2× 37 2.3k
Sybille Thoma-Uszynski Germany 15 584 0.6× 825 1.7× 386 0.8× 1.4k 3.0× 75 0.2× 22 2.8k
Kanji Hirai Japan 35 235 0.3× 565 1.2× 581 1.2× 737 1.6× 108 0.3× 147 3.7k
Howard Steinberg United States 27 94 0.1× 467 1.0× 533 1.1× 590 1.3× 153 0.4× 112 2.6k
George W. Jordan United States 21 175 0.2× 339 0.7× 228 0.5× 476 1.0× 57 0.1× 47 1.8k
D Olive France 26 65 0.1× 536 1.1× 778 1.6× 1.0k 2.3× 174 0.4× 90 3.1k

Countries citing papers authored by P. Herzer

Since Specialization
Citations

This map shows the geographic impact of P. Herzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Herzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Herzer more than expected).

Fields of papers citing papers by P. Herzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Herzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Herzer. The network helps show where P. Herzer may publish in the future.

Co-authorship network of co-authors of P. Herzer

This figure shows the co-authorship network connecting the top 25 collaborators of P. Herzer. A scholar is included among the top collaborators of P. Herzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Herzer. P. Herzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strangfeld, Anja, et al.. (2018). THU0192 Retention rates for etanercept: comparing the original with a biosimilar. Annals of the Rheumatic Diseases. 77. 315–316. 1 indexed citations
2.
Klein, Reinhild, et al.. (2017). Zwei Kinder mit intermediärer Uveitis und Granuloma anulare in derselben Nachbarschaft. Der Ophthalmologe. 114(12). 1155–1157.
3.
Strangfeld, Anja, Adrian Richter, Britta Siegmund, et al.. (2016). Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs. Annals of the Rheumatic Diseases. 76(3). 504–510. 142 indexed citations
4.
Kuhn, Annegret, Gisela Bonsmann, Hans‐Joachim Anders, et al.. (2015). The Diagnosis and Treatment of Systemic Lupus Erythematosus. Deutsches Ärzteblatt international. 112(25). 423–32. 151 indexed citations
5.
Herzer, P., Volker Fingerle, Hans‐Walter Pfister, & Andreas Krause. (2014). Lyme-Borreliose. Der Internist. 55(7). 789–804. 4 indexed citations
6.
Zink, A., Anja Strangfeld, Matthias Schneider, et al.. (2006). Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: Comparison of patients according to their eligibility for major randomized clinical trials. Arthritis & Rheumatism. 54(11). 3399–3407. 179 indexed citations
7.
Listing, Joachim, Anja Strangfeld, S. Kary, et al.. (2005). Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis & Rheumatism. 52(11). 3403–3412. 512 indexed citations breakdown →
8.
Zink, A., Joachim Listing, S. Kary, et al.. (2005). Treatment continuation in patients receiving biological agents or conventional DMARD therapy. Annals of the Rheumatic Diseases. 64(9). 1274–1279. 126 indexed citations
9.
Herzer, P., et al.. (2005). Systemic lupus erythematosus. DMW - Deutsche Medizinische Wochenschrift. 130(43). 2451–2458. 5 indexed citations
10.
Siegmund, Britta, C Folwaczny, Lutz Bader, et al.. (2000). Multiple Muskelabszesse bei tibetanischer Patientin. Der Internist. 41(9). 903–907. 2 indexed citations
11.
Herzer, P., et al.. (1998). Heterogeneity of Borrelia burgdorferi sensu lato demonstrated by an ospA -type-specific PCR in synovial fluid from patients with Lyme arthritis. Medical Microbiology and Immunology. 187(2). 97–102. 50 indexed citations
12.
Kellner, H., et al.. (1994). Seronegative spondylarthropathies in HIV-infected patients: further evidence of uncommon clinical features. Rheumatology International. 13(5). 211–213. 9 indexed citations
13.
Wilske, Bettina, Volker Fingerle, P. Herzer, et al.. (1993). Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Medical Microbiology and Immunology. 182(5). 255–270. 84 indexed citations
14.
Herzer, P.. (1993). Rheumatic manifestations in Lyme borreliosis. Clinics in Dermatology. 11(3). 401–406. 4 indexed citations
15.
Krause, Andreas, Gerd R Burmester, Christoph Schoerner, et al.. (1992). Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.. Journal of Clinical Investigation. 90(3). 1077–1084. 48 indexed citations
16.
Herzer, P., S Inouye, & Masayori Inouye. (1992). Retron‐Ec107 is inserted into the Escherichia coli genome by replacing a palindromic 34bp intergenic sequence. Molecular Microbiology. 6(3). 345–354. 26 indexed citations
17.
Herzer, P., et al.. (1992). Sequence diversity of the 1.3 kb retron (retron‐Ec107) among three distinct phylogenetic groups of Escherichia coli. Molecular Microbiology. 6(3). 355–361. 12 indexed citations
18.
Herzer, P.. (1991). Joint manifestations of Lyme borreliosis in Europe.. PubMed. 77. 55–63. 30 indexed citations
19.
Schewe, Stefan, P. Herzer, & K. Krüger. (1990). Prospective application of an expert system for the medical history of joint pain. Journal of Molecular Medicine. 68(9). 466–471. 9 indexed citations
20.
Herzer, P., et al.. (1982). Eosinophile Fasziitis (Shulman-Syndrom). Journal of Molecular Medicine. 60(21). 1319–1328. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026